1. Home
  2. XXII vs NDRA Comparison

XXII vs NDRA Comparison

Compare XXII & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$1.04

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Logo ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences Inc.

HOLD

Current Price

$5.79

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XXII
NDRA
Founded
1998
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
7.3M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
XXII
NDRA
Price
$1.04
$5.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$38.00
AVG Volume (30 Days)
190.3K
84.0K
Earning Date
11-04-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,346,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$136.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.98
N/A
52 Week Low
$0.78
$2.90
52 Week High
$294.98
$11.96

Technical Indicators

Market Signals
Indicator
XXII
NDRA
Relative Strength Index (RSI) 47.06 51.99
Support Level $0.98 $5.08
Resistance Level $1.09 $6.24
Average True Range (ATR) 0.09 0.82
MACD 0.04 0.01
Stochastic Oscillator 83.36 64.77

Price Performance

Historical Comparison
XXII
NDRA

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Share on Social Networks: